A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61P 19/02 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2532742
The invention refers to the use of a p21 -activated kinase (PAK) inhibitor for the treatment of a joint disease such as osteoarthritis or rheumatoid arthritis or for the treatment of a joint pain and the use of PAK as a target protein for the discovery of a PAK inhibitor as a medicament for the treatment of a joint disease.
L'invention concerne l'utilisation d'un inhibiteur de la kinase activée par p21 (PAK) pour le traitement d'une maladie des articulations telle que l'arthrose ou la polyarthrite rhumatoïde, ou pour le traitement d'une douleur articulaire. Elle concerne également l'utilisation de la PAK comme protéine cible en vue de découvrir un inhibiteur de la PAK en tant que médicament pour le traitement d'une maladie des articulations.
Barradeau Sebastian
Bartnik Eckart
Czech Joerg
Klatt Andreas R.
Leberer Ekkehard
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Use of a pak inhibitor for the treatment of a joint disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a pak inhibitor for the treatment of a joint disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a pak inhibitor for the treatment of a joint disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1550434